]>
IRCT201109122306N4 IRCT 2012-07-26 Vice chancellery for research, Isfahan University of Medical Sciences Preliminary clinical evaluation of Portulaca oleraceae seed on treatment of dyslipidemia in adolescents Clinical evaluation of Portulaca oleraceae seed in comparision with placebo on treatment of dyslipidemia in adolescents between 12-18 years old 2011-05-05 anticipated 74 Complete https://irct.ir/trial/1944 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention. N/A Dyslipidemia. Intervention 1: Portulaca oleraceae seed powder in 500 mg capsules thrice a day for one month. Intervention 2: placebo powder in 500mg capsules thrice a day for one month.
public Hadi jelokhanian
Isfahan University of Medical Sciences, Daneshgah st. beginning, Azadi sq.Isfahan
Isfahan Iran (Islamic Republic of) +98 31 1336 8589 hadi_jelokhanian@yahoo.com Isfahan University of Medical Sciences scientific Hadi Jelokhanian
Isfahan University of Medical Sciences, Daneshgah st. beginning, Azadi sq., Isfahan
Isfahan Iran (Islamic Republic of) +98 31 1336 8589 hadi_jelokhanian@yahoo.com Isfahan University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: 1)adolescents between 12 to 18 years old that have at least one of these criteria: a: triglyceride more than 90 percentile b: total cholesterol more than 90 percentile c: LDL more than 90 percentile d:HDL less than 10 percentile 2) Not using tobacco 3) No history of alcohol consumption or drug abuse 4) No history of metabolic diseases like diabetes, thyroid gland dysfunction, nephrotic syndrome, chronic pancreatitis, liver and gall bladder diseases that affects lipid profiles 5) No use of drugs which affect lipid profiles like statins and hormonal pills like estrogens, progestrones and oral contraceptives. Exclusion criteria: 1) Lack of patient’s compliance with drug regimens at least for one week. 2) Pregnancy and lactation 3) Drug sensitivity 4) Suffering from any diseases which interact with lipid profiles 5) Intake of any kind of drugs or other compounds lowering lipid profile like corticosteroids, androgens, estrogenes, progestines, thiazides, beta blockers and thyroid hormones 12 years 18 years Both E78.5 Hyperlipidaemia,unspecified Treatment - Drugs Placebo Portulaca oleraceae seed powder in 500 mg capsules thrice a day for one month placebo powder in 500mg capsules thrice a day for one month HDL cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit. LDL cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit. Triglyceride. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit. Total cholestrol. Timepoint: Before intervention, one month after intervention. Method of measurement: mg/dl through using laboratory kit. Vice chancellery for research, Isfahan University of Medical Sciences Approved 2010-03-01 Isfahan University of Medical Sciences ethics Committee Vice chancellery for research, Isfahan University of Medical Sciences Isfahan Iran (Islamic Republic of)